Clinical trial
Study of Leptin for the Treatment of Hypothalamic Amenorrhea
NCT00130117 · Beth Israel Deaconess Medical Center, Other · Completed
Key facts
| NCT number | NCT00130117 |
|---|---|
| Title | Study of Leptin for the Treatment of Hypothalamic Amenorrhea |
| Official title | Randomized, Double-blind, Placebo-controlled Trial of Human Recombinant Leptin (r-metHuLeptin) for the Treatment of Hypothalamic (Exercise-Induced) Amenorrhea |
| Lead sponsor | Beth Israel Deaconess Medical Center, Other |
| Collaborators | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) NIH National Center for Research Resources (NCRR) Amgen Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Amenorrhea |
| Intervention type | Drug, Other |
| Interventions | r-metHuLeptin, Oral Contraceptive Pills (OCPs), Placebo |
| Enrollment | 20 |
| Start date | Apr 1, 2010 |
| Primary completion | Aug 1, 2011 |
| Completion | Dec 1, 2016 |
| First posted | Aug 15, 2005 |
| Last update posted | May 17, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: